The influence of age and sex on the clearance of cytochrome P450 3A substrates

被引:222
作者
Cotreau, MM
von Moltke, LL
Greenblatt, DJ
机构
[1] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
[2] Wyeth Ayerst Res, Expt Med, Cambridge, MA USA
关键词
D O I
10.2165/00003088-200544010-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450s (CYPs) are an important family of enzymes in the metabolism of many therapeutic agents and endogenous metabolic reactions. The CYP3A subfamily is especially prominent in these metabolic activities. This review article focuses on how the factors of age and sex may influence the in vivo activity of human CYP3A. The functional activity of CYP3A varies based on issues such as interaction with one or more substrates and between individuals and/or localisation. For CYP3A substrates, intrinsic clearance is the component of total clearance that is contributed by the enzymes. Depending on the route of administration and the contribution of hepatic blood flow to overall clearance, sensitivities to changes in CYP3A activities may differ. Additionally, age may influence the hepatic blood flow and, in turn, affect CYP3A activity. A review of the literature regarding age influences on the clearance of CYP3A substrates does suggest that age can affect the clearance of certain CYP3A substrates. CYP3A is responsible for a large number of endogenous metabolic reactions involving steroid hormones, and enzyme activity has been reported to be induced and/or inhibited in the presence of some sex steroids. Based on published studies for most CYP3A substrates, sex does not appear to influence clearance; however, with certain substrates significant sex-related differences are found. In such cases, women primarily have higher clearance than men.
引用
收藏
页码:33 / 60
页数:28
相关论文
共 201 条
  • [131] Effect of age on in vitro triazolam biotransformation in male human liver microsomes
    Patki, KC
    von Moltke, LL
    Harmatz, JS
    Hesse, LM
    Court, MH
    Greenblatt, DJ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (03) : 874 - 879
  • [132] Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans
    Paulussen, A
    Lavrijsen, K
    Bohets, H
    Hendrickx, J
    Verhasselt, P
    Luyten, W
    Konings, F
    Armstrong, M
    [J]. PHARMACOGENETICS, 2000, 10 (05): : 415 - 424
  • [133] COCAINE N-DEMETHYLATION AND THE METABOLISM-RELATED HEPATOTOXICITY CAN BE PREVENTED BY CYTOCHROME-P450 3A INHIBITORS
    PELLINEN, P
    HONKAKOSKI, P
    STENBACK, F
    NIEMITZ, M
    ALHAVA, E
    PELKONEN, O
    LANG, MA
    PASANEN, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1994, 270 (01): : 35 - 43
  • [134] Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes:: involvement of CYP enzymes
    Pellinen, P
    Kulmala, L
    Konttila, J
    Auriola, S
    Pasanen, M
    Juvonen, R
    [J]. ARCHIVES OF TOXICOLOGY, 2000, 74 (09) : 511 - 520
  • [135] Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618
  • [136] PICHARD L, 1995, DRUG METAB DISPOS, V23, P1253
  • [137] PICHARD L, 1990, DRUG METAB DISPOS, V18, P595
  • [138] PICHARD L, 1992, MOL PHARMACOL, V41, P1047
  • [139] Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction
    Platten, HP
    Schweizer, E
    Dilger, K
    Mikus, G
    Klotz, U
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (05) : 552 - 560
  • [140] AGE-RELATED-CHANGES IN THE PHARMACOKINETICS AND PHARMACODYNAMICS OF NIFEDIPINE
    ROBERTSON, DRC
    WALLER, DG
    RENWICK, AG
    GEORGE, CF
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (03) : 297 - 305